OR WAIT null SECS
February 06, 2019
In a deal potentially worth up to $460 million, Genentech and Xencor will develop and commercialize novel cytokine therapeutics.
February 01, 2019
The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.
Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.
January 25, 2019
Full commercial launch of the drug is underway in the United States, with Europe to follow.
G-CON will provide a complete cleanroom infrastructure for GE Healthcare’s cell therapy and viral vector production platforms that will simplify early-stage manufacturing efforts.
January 18, 2019
MilliporeSigma’s use of modified amino acids can simplify the fed-batch process in biomanufacturing.
January 15, 2019
The agreement gives Sanofi access to Biomunex’s proprietary bi- and multi-specific-antibody-generating platform.
January 14, 2019
The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.
January 11, 2019
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) revealed 22 new projects and funding aimed to advance US biopharmaceutical manufacturing.
The companies will collaborate to improve the manufacturability for two of Sanofi’s biotherapeutics.